National Eye Institute; Notice of Closed Meetings, 12916-12917 [2016-05427]
Download as PDF
asabaliauskas on DSK3SPTVN1PROD with NOTICES
12916
Federal Register / Vol. 81, No. 48 / Friday, March 11, 2016 / Notices
research. Specifically, the workshop
will seek to clarify the following
questions:
• Key Question 1: How can national,
state, and community data systems be
linked to existing data from suicide
prevention efforts in order to add
possible value for stakeholders? What
methods are available to link the data
systems?
• Key Question 2: Which statistical
methods are reliable and valid for
understanding possible mediators and
moderators in suicide prevention
programs to improve targeting
interventions to populations?
• Key Question 3: Which statistical
methods are reliable and valid for
analyzing linked national, state, and
community data systems and suicide
prevention data to avoid misleading
conclusions?
• Key Question 4: Given the current
state of research, what types of
methodological/analytic advances
would promote further evaluation of
youth suicide prevention efforts (e.g.,
new approaches to data linkage;
increased use of common data elements;
approaches to intervention
harmonization) and facilitate
intervention selection and
implementation decisions by local
community and state-level
policymakers?
• Key Question 5: What is the way
forward that will help the suicide
prevention research community realize
the potential benefits of early
prevention? What are the immediate
and longer-term research investments
needed to accomplish this?
Initial planning for each Pathways to
Prevention workshop, regardless of the
topic, is coordinated by a Content-Area
Expert Group that nominates panelists
and speakers and develops and finalizes
questions that frame the workshop.
After the questions are finalized, an
evidence report is prepared by an
Evidence-based Practice Center, through
a contract with the Agency for
Healthcare Research and Quality.
During the 11⁄2-day workshop, invited
experts discuss the body of evidence,
and attendees provide comments during
open discussion periods. After weighing
evidence from the evidence report,
expert presentations, and public
comments, an unbiased, independent
panel prepares a draft report that
identifies research gaps and future
research priorities. The draft report is
posted on the ODP Web site for public
comment. After reviewing the public
comments, the panel prepares a final
report, which is also posted on the ODP
Web site. The ODP then convenes a
Federal Partners Meeting to review the
VerDate Sep<11>2014
17:56 Mar 10, 2016
Jkt 238001
panel report and identify possible
opportunities for collaboration.
Please Note: As part of measures to
ensure the safety of NIH employees and
property, all visitors must be prepared
to show a photo ID upon request.
Visitors may be required to pass through
a metal detector and have bags,
backpacks, or purses inspected or
x-rayed as they enter the NIH campus.
For more information about the security
measures at the NIH, please visit
.
Dated: March 7, 2016.
Lawrence A. Tabak,
Deputy Director, National Institutes of Health.
[FR Doc. 2016–05564 Filed 3–10–16; 8:45 am]
Place: National Institute of Health, 5635
Fishers Lane, Bethesda, MD 20814 (Virtual
Meeting).
Contact Person: Anna E Mazzucco, Ph.D.,
Scientific Review Officer, National Eye
Institute, National Institutes of Health,
Division of Extramural Research, 5635
Fishers Lane, Suite 1300, Bethesda, MD
20852, 301–594–6074, anna.mazzucco@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: March 7, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–05428 Filed 3–10–16; 8:45 am]
BILLING CODE 4140–01–P
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI RFA–EY–15–
002 Factors Influencing Neural Regeneration
in the Visual System.
Date: April 7, 2016.
Time: 8:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Brian Hoshaw, Ph.D.,
Scientific Review Officer, National Eye
Institute, National Institutes of Health,
Division of Extramural Research, 5635
Fishers Lane, Suite 1300, Rockville, MD
20892, 301–451–2020, hoshawb@
mail.nih.gov.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Loan
Repayment Program Applications.
Date: April 7–8, 2016.
Time: 9:00 a.m. to 4:30 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Pathways to
Independence Grant Applications (K99).
Date: April 4–6, 2016.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 5635
Fishers Lane, Bethesda, MD 20892 (Virtual
Meeting).
Contact Person: Anne E. Schaffner, Ph.D.,
Chief, Scientific Review Branch Division of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300, MSC 9300,
Bethesda, MD 20892–9300, (301) 451–2020,
aes@nei.nih.gov.
Name of Committee: National Eye Institute
Special Emphasis Panel; NEI Cooperative
Agreement and Clinically-Oriented
Applications.
Date: April 18, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Place: Embassy Suites at the Chevy Chase
Pavilion, 4300 Military Road NW.,
Washington, DC 20015.
E:\FR\FM\11MRN1.SGM
11MRN1
12917
Federal Register / Vol. 81, No. 48 / Friday, March 11, 2016 / Notices
Contact Person: Anne E. Schaffner, Ph.D.,
Chief, Scientific Review Branch Division of
Extramural Research, National Eye Institute,
5635 Fishers Lane, Suite 1300, MSC 9300,
Bethesda, MD 20892–9300, (301) 451–2020,
aes@nei.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.867, Vision Research,
National Institutes of Health, HHS)
Dated: March 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–05427 Filed 3–10–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Proposed Collection;
Comment Request
In compliance with Section
3506(c)(2)(A) of the Paperwork
Reduction Act of 1995 concerning
opportunity for public comment on
proposed collections of information, the
Substance Abuse and Mental Health
Services Administration (SAMHSA)
will publish periodic summaries of
proposed projects. To request more
information on the proposed projects or
to obtain a copy of the information
collection plans, call the SAMHSA
Reports Clearance Officer on (240) 276–
1243.
Comments are invited on: (a) Whether
the proposed collections of information
are necessary for the proper
performance of the functions of the
agency, including whether the
information shall have practical utility;
(b) the accuracy of the agency’s estimate
of the burden of the proposed collection
of information; (c) ways to enhance the
quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Proposed Project: Primary and
Behavioral Health Care Integration
Evaluation—NEW
The Substance Abuse and Mental
Health Services Administration’s
(SAMHSA) Center for Behavioral Health
Statistics and Quality (CBHSQ) is
requesting approval from the Office of
Management and Budget (OMB) for new
data collection activities associated with
their Primary and Behavioral Health
Care Integration (PBHCI) program.
This information collection is needed
to provide SAMHSA with objective
information to document the reach and
impact of the PBHCI program. The
information will be used to monitor
quality assurance and quality
performance outcomes for organizations
funded by this grant program. The
information will also be used to assess
the impact of services on behavioral
health and physical health services for
individuals served by this program.
Collection of the information
included in this request is authorized by
Section 505 of the Public Health Service
Act (42 U.S.C. 290aa–4)—Data
Collection.
SAMHSA launched the PBHCI
program in FY 2009 with the
understanding that adults with serious
mental illness (SMI) experience
heightened rates of morbidity and
mortality, in large part due to elevated
incidence and prevalence of risk factors
such as obesity, diabetes, hypertension,
and dyslipidemia. These risk factors are
influenced by a variety of factors,
including inadequate physical activity
and poor nutrition; smoking; side effects
from atypical antipsychotic
medications; and lack of access to
health care services. Many of these
health conditions are preventable
through routine health promotion
activities, primary care screening,
monitoring, treatment and care
management/coordination strategies
and/or other outreach programs.
The purpose of the PBHCI grant
program is to establish projects for the
provision of coordinated and integrated
services through the co-location of
primary and specialty care medical
services in community-based behavioral
Number of
respondents
asabaliauskas on DSK3SPTVN1PROD with NOTICES
Respondents/activity
Web surveys:
Grantee director ..........................................................
Grantee frontline staff survey .....................................
Phone interviews:
Grantee director ..........................................................
Grantee director—site interview .................................
Grantee mental health providers—site interview .......
Grantee primary care providers—site interview .........
Grantee care coordinators—site interview .................
VerDate Sep<11>2014
17:56 Mar 10, 2016
Jkt 238001
PO 00000
Frm 00060
Responses per
respondent
health settings. The program’s goal is to
improve the physical health status of
adults with serious mental illnesses
(and those with co-occurring substance
use disorders) who have or are at risk
for co-occurring primary care conditions
and chronic diseases.
As the largest federal effort to
implement integrated behavioral and
physical health care in community
behavioral health settings, SAMHSA’s
PBHCI program offers an unprecedented
opportunity to identify which
approaches to integration improve
outcomes, how outcomes are shaped by
the characteristics of the treatment
setting and community, and which
models have the greatest potential for
sustainability and replication. SAMHSA
awarded the first cohort of 13 PBHCI
grants in fiscal year (FY) 2009, and
between FY 2009 and FY 2014,
SAMHSA funded a total of seven
cohorts comprising 127 grants. An
eighth cohort, funded in fall 2015,
included 60 new grants.
The data collection described in this
request will build upon the first PBHCI
evaluation and provide essential data on
the implementation of integrated
primary and behavioral health care,
along with rigorous estimates of its
effects on health.
The Center for Behavioral Health
Statistics and Quality is requesting
clearance for ten data collection
instruments and forms related to the
implementation and impact studies to
be conducted as part of the evaluation:
1. PBHCI grantee director survey
2. PBHCI frontline staff survey
3. Telephone interview protocol
4. On-site staff interview protocol
5. Client focus group guide
6. Data extraction tool for grantee
registry/electronic health records
(EHRs)
7. Initial client letter for physical exam
and health assessment
8. Consent form for client physical exam
and health assessment
9. Consent form for client focus group
10. Client physical exam and health
assessment questionnaire
The table below reflects the
annualized hourly burden.
Total
responses
b 149
Hours per
response
Total hour
burden
b 75
78
782
2
2
c 1,494
0.5
0.5
c 747
60
10
40
40
20
1
2
2
2
2
60
20
80
80
40
1.0
2.0
1.0
1.5
1.5
60
40
80
120
60
Fmt 4703
Sfmt 4703
E:\FR\FM\11MRN1.SGM
11MRN1
Agencies
[Federal Register Volume 81, Number 48 (Friday, March 11, 2016)]
[Notices]
[Pages 12916-12917]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-05427]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Eye Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Eye Institute Special Emphasis
Panel; NEI Pathways to Independence Grant Applications (K99).
Date: April 4-6, 2016.
Time: 8:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 5635 Fishers Lane,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Anne E. Schaffner, Ph.D., Chief, Scientific
Review Branch Division of Extramural Research, National Eye
Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD
20892-9300, (301) 451-2020, aes@nei.nih.gov.
Name of Committee: National Eye Institute Special Emphasis
Panel; NEI Cooperative Agreement and Clinically-Oriented
Applications.
Date: April 18, 2016.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Place: Embassy Suites at the Chevy Chase Pavilion, 4300 Military
Road NW., Washington, DC 20015.
[[Page 12917]]
Contact Person: Anne E. Schaffner, Ph.D., Chief, Scientific
Review Branch Division of Extramural Research, National Eye
Institute, 5635 Fishers Lane, Suite 1300, MSC 9300, Bethesda, MD
20892-9300, (301) 451-2020, aes@nei.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.867,
Vision Research, National Institutes of Health, HHS)
Dated: March 4, 2016.
Natasha M. Copeland,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-05427 Filed 3-10-16; 8:45 am]
BILLING CODE 4140-01-P